GLP-1s
US$ 29.02
glp 1 agonist effects The cardiovascular of GLP-1 receptor agonists beyond obesity and type 2 diabetes: An anti-atherosclerotic action GI Adverse Effects of Glucagon-Like
Description
The majority of studies indicate that defective GLP-1 secretion does not appear to predate the development of glucose intolerance, rather diabetes itself seems to be associated with the acquired defect in GLP-1 secretion and GIP action [23]
Liraglutide directly protects cardiomyocytes against reperfusion injury possibly via modulation of intracellular calcium homeostasis
Exenatide improves type 2 diabetes concomitant with non-alcoholic fatty liver disease
doi: 10.12788/cutis.0262
